Actionable news
0
All posts from Actionable news
Actionable news in JNJ: JOHNSON & JOHNSON,

Johnson & Johnson Prescribes a Dose of Value, Healthy Dividend

NEW YORK (TheStreet) -- Global health care giant Johnson & Johnson (JNJ - Get Report) will report third-quarter earnings ahead of the opening bell Tuesday. With the company's stock down more than 9% on the year and down 7% in the past six months, there's an implied 15% gain based on its average analyst 12-month price target of $109. The stock currently trades around $95, making it a solid value play ahead of Tuesday's results.

For the quarter that ended in September, the average analyst earnings-per-share estimates calls for $1.45 a share on revenue of $17.47 billion, compared to the year-ago quarter when Johnson & Johnson earned $1.61 a share on $18.47 billion. For the full-year, earnings are projected to fall 3% year over year to $6.17 a share, while revenue of $70.7 billion would mark a...


More